QQ客服 官方微博 反馈留言

	Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1
	Zhou, Jing; Yu, Qi; Chen, Rong; Seeger, Harald; Fehm, Tanja; Cahill, Michael A.; Mueck, Alfred O.; Neubauer, Hans
	2013
卷号	76期号:2页码:129-133
关键词	Medroxyprogesterone acetate Growth factors Breast cancer cells Progesterone receptor membrane component-1 Proliferation
ISSN号	0378-5122
DOI	10.1016/j.maturitas.2013.06.013
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6706041
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhou, Jing,Yu, Qi,Chen, Rong,et al. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1[J],2013,76(2):129-133.
APA	Zhou, Jing.,Yu, Qi.,Chen, Rong.,Seeger, Harald.,Fehm, Tanja.,...&Neubauer, Hans.(2013).Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.,76(2),129-133.
MLA	Zhou, Jing,et al."Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1".76.2(2013):129-133.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。